MENU
KLRS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Kalaris Therapeutics (KLRS) Earnings Date & Reports
Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases... Show more
A.I. Advisor
published Earnings
KLRS is expected to report earnings to rise 9.00% to -50 cents per share on August 19
Q2'26
Est.
$-0.50
Q1'26
Beat
by $0.10
Q4'25
Missed
by $0.34
The last earnings report on May 12 showed earnings per share of -46 cents, beating the estimate of -56 cents. With 2.92K shares outstanding, the current market capitalization sits at 104.69M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information